Skip to main content
Top
Published in: Diagnostic Pathology 1/2013

Open Access 01-12-2013 | Research

Immunophenotypic features and t(14;18) (q32;q21) translocation of Chinese follicular lymphomas helps to distinguish subgroups

Authors: Fen Zhang, Li-Xu Yan, Su-Xia Lin, Zi-Yin Ye, Heng-Guo Zhuang, Jing-Ping Yun, Han-Liang Lin, Dong-Lan Luo, Fang-Ping Xu, Xin-Lan Luo, Jie Cheng, Ke-Ping Zhang, Yan-Hui Liu

Published in: Diagnostic Pathology | Issue 1/2013

Login to get access

Abstract

Background

The revised 2008 World Health Organization classification maintains a histological grading system (grades 1–3) for follicular lymphoma (FL). The value of grading FL has been debated. This study will yield deeper insights into the morphologic, immunophenotypic characterization and t(14;18) translocation in FL and explore their significance of diagnosis of Chinese FL subgroups.

Methods

We retrospectively reviewed the FL diagnoses according to the 2008 WHO classification in all diagnostic specimens from a multicentric cohort of 122 Chinese patients. Upon review, 115 cases proved to be truly FL. CD10, BCL6, MUM1, BCL2 and t(14;18) (q32;q21) translocation were detected by Envision immunostaining technique and fluorescence in situ hybridization.

Results

FL1 has larger proportion of follicular pattern (93.0%) than that of FL2 (73.7%, P = 0.036), FL3B (63.6%, P = 0.003) and FL3A (77.4%, P = 0.053), although the last P value was more than 0.05 (Pearson’s chi-squared test). Areas of DLBCL were present in 25.8% (8/31) of FL3A and more frequent in FL3B (59.1%, 13/22; P = 0.015). The positivity of CD10 and BCL2 in FL1-2 were significantly higher than those in FL3 (P < 0.001, P = 0.043, respectively). The positivity of MUM1 in FL1-2 was significantly lower than that in FL3 (10.2% vs. 51.0%; P < 0.001). Furthermore the positivity of MUM1 in FL3A was significantly lower than that in FL3B (37.9% vs. 68.2%; P = 0.032). The positivity of t(14;18) was higher in FL1-2 than in FL3 (73.5% vs. 35.6%, P < 0.001), and was higher in FL3A than in FL3B (51.9% vs. 11.1%, P = 0.005). t(14;18) was significantly correlated with CD10+ (R = 0.453, P < 0.001) and MUM1+ (R = -0.482, P < 0.001).

Conclusions

FL1 and FL2 were immunophenotypically and genomically similar, while FL3A and FL3B were partly immunophenotypically similar but morphologically, genomically distinct. FL3A was genomically closer to FL1-2, whereas FL3A was genomically closer DLBCL. Thus we hypothesize that FL may in fact be a heterogeneous indolent lymphoma encompassing entities with distinct molecular pathogenesis and genetic characteristics. Immunohistochemical and genetic characterization helps to distinguish subgroups of FLs.

Virtual slides

The virtual slide(s) for this article can be found here: http://​www.​diagnosticpathol​ogy.​diagnomx.​eu/​vs/​1334018129864616​.
Appendix
Available only for authorised users
Literature
1.
go back to reference Groves FD, Linet MS, Travis LB, Devesa SS: Cancer surveillance series: non-Hodgkin’s lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst. 2000, 92 (15): 1240-1251. 10.1093/jnci/92.15.1240.CrossRefPubMed Groves FD, Linet MS, Travis LB, Devesa SS: Cancer surveillance series: non-Hodgkin’s lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst. 2000, 92 (15): 1240-1251. 10.1093/jnci/92.15.1240.CrossRefPubMed
2.
go back to reference Bosga-Bouwer AG, van den Berg A, Haralambieva E, de Jong D, Boonstra R, Kluin P, van den Berg E, Poppema S: Molecular, cytogenetic, and immunophenotypic characterization of follicular lymphoma grade 3B; a separate entity or part of the spectrum of diffuse large B-cell lymphoma or follicular lymphoma?. Human pathology. 2006, 37 (5): 528-533. 10.1016/j.humpath.2005.12.005.CrossRefPubMed Bosga-Bouwer AG, van den Berg A, Haralambieva E, de Jong D, Boonstra R, Kluin P, van den Berg E, Poppema S: Molecular, cytogenetic, and immunophenotypic characterization of follicular lymphoma grade 3B; a separate entity or part of the spectrum of diffuse large B-cell lymphoma or follicular lymphoma?. Human pathology. 2006, 37 (5): 528-533. 10.1016/j.humpath.2005.12.005.CrossRefPubMed
3.
go back to reference Karube K, Guo Y, Suzumiya J, Sugita Y, Nomura Y, Yamamoto K, Shimizu K, Yoshida S, Komatani H, Takeshita M, Kikuchi M, Nakamura N, Takasu O, Arakawa F, Tagawa H, Seto M, Ohshima K: CD10-MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features. Blood. 2007, 109 (7): 3076-3079.PubMed Karube K, Guo Y, Suzumiya J, Sugita Y, Nomura Y, Yamamoto K, Shimizu K, Yoshida S, Komatani H, Takeshita M, Kikuchi M, Nakamura N, Takasu O, Arakawa F, Tagawa H, Seto M, Ohshima K: CD10-MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features. Blood. 2007, 109 (7): 3076-3079.PubMed
4.
go back to reference Ott G, Katzenberger T, Lohr A, Kindelberger S, Rudiger T, Wilhelm M, Kalla J, Rosenwald A, Muller JG, Ott MM, Muller-Hermelink HK: Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. Blood. 2002, 99 (10): 3806-3812. 10.1182/blood.V99.10.3806.CrossRefPubMed Ott G, Katzenberger T, Lohr A, Kindelberger S, Rudiger T, Wilhelm M, Kalla J, Rosenwald A, Muller JG, Ott MM, Muller-Hermelink HK: Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. Blood. 2002, 99 (10): 3806-3812. 10.1182/blood.V99.10.3806.CrossRefPubMed
5.
go back to reference Carbone A, Gloghini A, Aldinucci D, Gattei V, Dalla-Favera R, Gaidano G: Expression pattern of MUM1/IRF4 in the spectrum of pathology of Hodgkin’s disease. Br J Haematol. 2002, 117 (2): 366-372. 10.1046/j.1365-2141.2002.03456.x.CrossRefPubMed Carbone A, Gloghini A, Aldinucci D, Gattei V, Dalla-Favera R, Gaidano G: Expression pattern of MUM1/IRF4 in the spectrum of pathology of Hodgkin’s disease. Br J Haematol. 2002, 117 (2): 366-372. 10.1046/j.1365-2141.2002.03456.x.CrossRefPubMed
6.
go back to reference Papakonstantinou G, Verbeke C, Hastka J, Bohrer M, Hehlmann R: bcl-2 expression in non-Hodgkin’s lymphomas is not associated with bcl-2 gene rearrangements. Br J Haematol. 2001, 113 (2): 383-390. 10.1046/j.1365-2141.2001.02727.x.CrossRefPubMed Papakonstantinou G, Verbeke C, Hastka J, Bohrer M, Hehlmann R: bcl-2 expression in non-Hodgkin’s lymphomas is not associated with bcl-2 gene rearrangements. Br J Haematol. 2001, 113 (2): 383-390. 10.1046/j.1365-2141.2001.02727.x.CrossRefPubMed
7.
go back to reference Peh SC, Shaminie J, Tai YC, Tan J, Gan SS: The pattern and frequency of t(14;18) translocation and immunophenotype in Asian follicular lymphoma. Histopathology. 2004, 45 (5): 501-510. 10.1111/j.1365-2559.2004.01979.x.CrossRefPubMed Peh SC, Shaminie J, Tai YC, Tan J, Gan SS: The pattern and frequency of t(14;18) translocation and immunophenotype in Asian follicular lymphoma. Histopathology. 2004, 45 (5): 501-510. 10.1111/j.1365-2559.2004.01979.x.CrossRefPubMed
8.
go back to reference Horn H, Schmelter C, Leich E, Salaverria I, Katzenberger T, Ott MM, Kalla J, Romero M, Siebert R, Rosenwald A, Rosenwald A, Ott G: Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles. Haematologica. 2011, 96 (9): 1327-1334. 10.3324/haematol.2011.042531.PubMedCentralCrossRefPubMed Horn H, Schmelter C, Leich E, Salaverria I, Katzenberger T, Ott MM, Kalla J, Romero M, Siebert R, Rosenwald A, Rosenwald A, Ott G: Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles. Haematologica. 2011, 96 (9): 1327-1334. 10.3324/haematol.2011.042531.PubMedCentralCrossRefPubMed
9.
go back to reference Einerson RR, Kurtin PJ, Dayharsh GA, Kimlinger TK, Remstein ED: FISH is superior to PCR in detecting t(14;18)(q32;q21)-IgH/bcl-2 in follicular lymphoma using paraffin-embedded tissue samples. Am J Clin Pathol. 2005, 124 (3): 421-429. 10.1309/BLH8MMK85UBQ4K6R.CrossRefPubMed Einerson RR, Kurtin PJ, Dayharsh GA, Kimlinger TK, Remstein ED: FISH is superior to PCR in detecting t(14;18)(q32;q21)-IgH/bcl-2 in follicular lymphoma using paraffin-embedded tissue samples. Am J Clin Pathol. 2005, 124 (3): 421-429. 10.1309/BLH8MMK85UBQ4K6R.CrossRefPubMed
10.
go back to reference Chang X, Zu Lan S, Qiu Liang W, Hong Yi G, Jian Chen F, Zhong Jun X, Zhong Zhen G: Clinical and pathological reassessment of 493 cases of non-Hodgkin’s lymphomas according to current WHO classification of lymphoid neoplasms. Chin J Pathol. 2005, 34 (1): 22-27. Chang X, Zu Lan S, Qiu Liang W, Hong Yi G, Jian Chen F, Zhong Jun X, Zhong Zhen G: Clinical and pathological reassessment of 493 cases of non-Hodgkin’s lymphomas according to current WHO classification of lymphoid neoplasms. Chin J Pathol. 2005, 34 (1): 22-27.
11.
go back to reference Goteri G, Lucarini G, Zizzi A, Costagliola A, Giantomassi F, Stramazzotti D, Rubini C, Leoni P: Comparison of germinal center markers CD10, BCL6 and human germinal center-associated lymphoma (HGAL) in follicular lymphomas. Diagn Pathol. 2011, 6: 97-10.1186/1746-1596-6-97.PubMedCentralCrossRefPubMed Goteri G, Lucarini G, Zizzi A, Costagliola A, Giantomassi F, Stramazzotti D, Rubini C, Leoni P: Comparison of germinal center markers CD10, BCL6 and human germinal center-associated lymphoma (HGAL) in follicular lymphomas. Diagn Pathol. 2011, 6: 97-10.1186/1746-1596-6-97.PubMedCentralCrossRefPubMed
12.
go back to reference Xiao Qiu L, Di Gan L, Zi Fen G, Xiao Ge Z, Xiong Zeng Z, Group TCLS: Distribution pattern of lymphoma subtypes in China: A nationwide multicenter study of 10002 cases. J Diagn Concepts Pract. 2012, 11 (2): 111-115. Xiao Qiu L, Di Gan L, Zi Fen G, Xiao Ge Z, Xiong Zeng Z, Group TCLS: Distribution pattern of lymphoma subtypes in China: A nationwide multicenter study of 10002 cases. J Diagn Concepts Pract. 2012, 11 (2): 111-115.
13.
go back to reference Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW: WHO classification of tumors of haematopoietic and lymphoid tissues. 2008, France: IARC press Lyon, 220-226. 4 Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW: WHO classification of tumors of haematopoietic and lymphoid tissues. 2008, France: IARC press Lyon, 220-226. 4
14.
go back to reference Yang QP, Zhang WY, Yu JB, Zhao S, Xu H, Wang WY, Bi CF, Zuo Z, Wang XQ, Huang J, Dai L, Liu WP: Subtype distribution of lymphomas in Southwest China: analysis of 6,382 cases using WHO classification in a single institution. Diagn Pathol. 2011, 6: 77-10.1186/1746-1596-6-77.PubMedCentralCrossRefPubMed Yang QP, Zhang WY, Yu JB, Zhao S, Xu H, Wang WY, Bi CF, Zuo Z, Wang XQ, Huang J, Dai L, Liu WP: Subtype distribution of lymphomas in Southwest China: analysis of 6,382 cases using WHO classification in a single institution. Diagn Pathol. 2011, 6: 77-10.1186/1746-1596-6-77.PubMedCentralCrossRefPubMed
15.
go back to reference Hans CP, Weisenburger DD, Vose JM, Hock LM, Lynch JC, Aoun P, Greiner TC, Chan WC, Bociek RG, Bierman PJ, Armitage JO: A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival. Blood. 2003, 101 (6): 2363-2367. 10.1182/blood-2002-07-2298.CrossRefPubMed Hans CP, Weisenburger DD, Vose JM, Hock LM, Lynch JC, Aoun P, Greiner TC, Chan WC, Bociek RG, Bierman PJ, Armitage JO: A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival. Blood. 2003, 101 (6): 2363-2367. 10.1182/blood-2002-07-2298.CrossRefPubMed
16.
go back to reference Katzenberger T, Ott G, Klein T, Kalla J, Muller-Hermelink HK, Ott MM: Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component. Am J Pathol. 2004, 165 (2): 481-490. 10.1016/S0002-9440(10)63313-5.PubMedCentralCrossRefPubMed Katzenberger T, Ott G, Klein T, Kalla J, Muller-Hermelink HK, Ott MM: Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component. Am J Pathol. 2004, 165 (2): 481-490. 10.1016/S0002-9440(10)63313-5.PubMedCentralCrossRefPubMed
17.
go back to reference Prevodnik VK, Lavrencak J, Horvat M, Novakovic BJ: The predictive significance of CD20 expression in B-cell lymphomas. Diagn Pathol. 2011, 6: 33-10.1186/1746-1596-6-33.PubMedCentralCrossRefPubMed Prevodnik VK, Lavrencak J, Horvat M, Novakovic BJ: The predictive significance of CD20 expression in B-cell lymphomas. Diagn Pathol. 2011, 6: 33-10.1186/1746-1596-6-33.PubMedCentralCrossRefPubMed
18.
go back to reference Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Muller-Hermelink HK, Campo E, Braziel RM, Jaffe ES, Pan Z, Farinha P, Smith LM, Falini B, Banham AH, Rosenwald A, Staudt LM, Connors JM, Armitage JO, Chan WC: Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004, 103 (1): 275-282. 10.1182/blood-2003-05-1545.CrossRefPubMed Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Muller-Hermelink HK, Campo E, Braziel RM, Jaffe ES, Pan Z, Farinha P, Smith LM, Falini B, Banham AH, Rosenwald A, Staudt LM, Connors JM, Armitage JO, Chan WC: Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004, 103 (1): 275-282. 10.1182/blood-2003-05-1545.CrossRefPubMed
19.
go back to reference Oh S, Koo DH, Suh C, Kim S, Park BH, Kang J, Huh J: Prognostic value of immunohistochemical biomarkers at different cut-off values in patients with diffuse large B-cell lymphoma treated with CHOP chemotherapy. J Korean med sci. 2011, 26 (12): 1556-1562. 10.3346/jkms.2011.26.12.1556.PubMedCentralCrossRefPubMed Oh S, Koo DH, Suh C, Kim S, Park BH, Kang J, Huh J: Prognostic value of immunohistochemical biomarkers at different cut-off values in patients with diffuse large B-cell lymphoma treated with CHOP chemotherapy. J Korean med sci. 2011, 26 (12): 1556-1562. 10.3346/jkms.2011.26.12.1556.PubMedCentralCrossRefPubMed
20.
go back to reference Bende RJ, Smit LA, van Noesel CJ: Molecular pathways in follicular lymphoma. Leukemia. 2007, 21 (1): 18-29. 10.1038/sj.leu.2404426.CrossRefPubMed Bende RJ, Smit LA, van Noesel CJ: Molecular pathways in follicular lymphoma. Leukemia. 2007, 21 (1): 18-29. 10.1038/sj.leu.2404426.CrossRefPubMed
21.
go back to reference Ngan BY, Chen-Levy Z, Weiss LM, Warnke RA, Cleary ML: Expression in non-Hodgkin’s lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation. N Engl J Med. 1988, 318 (25): 1638-1644. 10.1056/NEJM198806233182502.CrossRefPubMed Ngan BY, Chen-Levy Z, Weiss LM, Warnke RA, Cleary ML: Expression in non-Hodgkin’s lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation. N Engl J Med. 1988, 318 (25): 1638-1644. 10.1056/NEJM198806233182502.CrossRefPubMed
22.
go back to reference Lai R, Arber DA, Chang KL, Wilson CS, Weiss LM: Frequency of bcl-2 expression in non-Hodgkin’s lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia. Mod Pathol. 1998, 11 (9): 864-869.PubMed Lai R, Arber DA, Chang KL, Wilson CS, Weiss LM: Frequency of bcl-2 expression in non-Hodgkin’s lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia. Mod Pathol. 1998, 11 (9): 864-869.PubMed
23.
go back to reference Kishimoto K, Kitamura T, Fujita K, Tate G, Mitsuya T: Cytologic differential diagnosis of follicular lymphoma grades 1 and 2 from reactive follicular hyperplasia: cytologic features of fine-needle aspiration smears with Pap stain and fluorescence in situ hybridization analysis to detect t(14;18)(q32;q21) chromosomal translocation. Diagn Cytopathol. 2006, 34 (1): 11-17. 10.1002/dc.20381.CrossRefPubMed Kishimoto K, Kitamura T, Fujita K, Tate G, Mitsuya T: Cytologic differential diagnosis of follicular lymphoma grades 1 and 2 from reactive follicular hyperplasia: cytologic features of fine-needle aspiration smears with Pap stain and fluorescence in situ hybridization analysis to detect t(14;18)(q32;q21) chromosomal translocation. Diagn Cytopathol. 2006, 34 (1): 11-17. 10.1002/dc.20381.CrossRefPubMed
24.
go back to reference Sekiguchi N, Kobayashi Y, Yokota Y, Kusumoto S, Tanimoto K, Watanabe T, Matsuno Y, Tobinai K: Follicular lymphoma subgrouping by fluorescence in situ hybridization analysis. Cancer sci. 2005, 96 (2): 77-82. 10.1111/j.1349-7006.2005.00014.x.CrossRefPubMed Sekiguchi N, Kobayashi Y, Yokota Y, Kusumoto S, Tanimoto K, Watanabe T, Matsuno Y, Tobinai K: Follicular lymphoma subgrouping by fluorescence in situ hybridization analysis. Cancer sci. 2005, 96 (2): 77-82. 10.1111/j.1349-7006.2005.00014.x.CrossRefPubMed
25.
go back to reference Gollub W, Stassek B, Huckhagel T, Bernd HW, Krokowski M, Merz H, Feller AC, Thorns C: BCL6-translocations affect the phenotype of follicular lymphomas only in the absence of t(14;18)IgH/BCL2. Anticancer Res. 2009, 29 (11): 4649-4655.PubMed Gollub W, Stassek B, Huckhagel T, Bernd HW, Krokowski M, Merz H, Feller AC, Thorns C: BCL6-translocations affect the phenotype of follicular lymphomas only in the absence of t(14;18)IgH/BCL2. Anticancer Res. 2009, 29 (11): 4649-4655.PubMed
26.
go back to reference Liu YH, Xu FP, Zhuang HG, Lai KC, Xie D, Luo DL, Li L, Luo XL, Xu J, Zhang MH, Zhang F, Li HM: Clinicopathologic significance of immunophenotypic profiles related to germinal center and activation B-cell differentiation in diffuse large B-cell lymphoma from Chinese patients. Hum Pathol. 2008, 39 (6): 875-884. 10.1016/j.humpath.2007.10.013.CrossRefPubMed Liu YH, Xu FP, Zhuang HG, Lai KC, Xie D, Luo DL, Li L, Luo XL, Xu J, Zhang MH, Zhang F, Li HM: Clinicopathologic significance of immunophenotypic profiles related to germinal center and activation B-cell differentiation in diffuse large B-cell lymphoma from Chinese patients. Hum Pathol. 2008, 39 (6): 875-884. 10.1016/j.humpath.2007.10.013.CrossRefPubMed
27.
go back to reference Vega F, Medeiros LJ: Chromosomal translocations involved in non-Hodgkin lymphomas. Arch Pathol Lab Med. 2003, 127 (9): 1148-1160.PubMed Vega F, Medeiros LJ: Chromosomal translocations involved in non-Hodgkin lymphomas. Arch Pathol Lab Med. 2003, 127 (9): 1148-1160.PubMed
28.
go back to reference Schraders M, de Jong D, Kluin P, Groenen P, van Krieken H: Lack of Bcl-2 expression in follicular lymphoma may be caused by mutations in the BCL2 gene or by absence of the t(14;18) translocation. J Pathol. 2005, 205 (3): 329-335. 10.1002/path.1689.CrossRefPubMed Schraders M, de Jong D, Kluin P, Groenen P, van Krieken H: Lack of Bcl-2 expression in follicular lymphoma may be caused by mutations in the BCL2 gene or by absence of the t(14;18) translocation. J Pathol. 2005, 205 (3): 329-335. 10.1002/path.1689.CrossRefPubMed
29.
go back to reference Jost PJ, Ruland J: Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications. Blood. 2007, 109 (7): 2700-2707.PubMed Jost PJ, Ruland J: Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications. Blood. 2007, 109 (7): 2700-2707.PubMed
30.
go back to reference Bosga-Bouwer AG, van Imhoff GW, Boonstra R, van der Veen A, Haralambieva E, van den Berg A, de Jong B, Krause V, Palmer MC, Coupland R, Kluin PM, van den Berg E, Poppema S: Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive. Blood. 2003, 101 (3): 1149-1154. 10.1182/blood.V101.3.1149.CrossRefPubMed Bosga-Bouwer AG, van Imhoff GW, Boonstra R, van der Veen A, Haralambieva E, van den Berg A, de Jong B, Krause V, Palmer MC, Coupland R, Kluin PM, van den Berg E, Poppema S: Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive. Blood. 2003, 101 (3): 1149-1154. 10.1182/blood.V101.3.1149.CrossRefPubMed
Metadata
Title
Immunophenotypic features and t(14;18) (q32;q21) translocation of Chinese follicular lymphomas helps to distinguish subgroups
Authors
Fen Zhang
Li-Xu Yan
Su-Xia Lin
Zi-Yin Ye
Heng-Guo Zhuang
Jing-Ping Yun
Han-Liang Lin
Dong-Lan Luo
Fang-Ping Xu
Xin-Lan Luo
Jie Cheng
Ke-Ping Zhang
Yan-Hui Liu
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Diagnostic Pathology / Issue 1/2013
Electronic ISSN: 1746-1596
DOI
https://doi.org/10.1186/1746-1596-8-154

Other articles of this Issue 1/2013

Diagnostic Pathology 1/2013 Go to the issue